Ozdemir, N. Et Al. 2014. Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.20 , 8715-8718.

Ozdemir, N., Dogan, M., ŞENDUR, M. A. N., Yazici, O., Abali, H., Yazilitas, D., ... AKINCI, M. B.(2014). Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.20, 8715-8718.

Ozdemir, Nuriye Et Al. "Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.20, 8715-8718, 2014

Ozdemir, Nuriye Et Al. "Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.20, pp.8715-8718, 2014

Ozdemir, N. Et Al. (2014) . "Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.20, pp.8715-8718.

@article{article, author={Nuriye Ozdemir Et Al. }, title={Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2014, pages={8715-8718} }